TORRANCE, Calif., April 16, 2020 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today that the SFDA (Saudi Food & Drug Authority) ...
RIYADH — The Saudi Food and Drug Authority (SFDA) has approved the registration of Tzield (teplizumab) to delay the onset of Stage 3 type 1 diabetes in adults and pediatric patients 8 years of age and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback